Description
P-Predict is an application that predicts the effects of various doses of radiotherapy (RT) and durations of androgen deprivation therapy (ADT) on patients receiving definitive RT for prostate cancer.
P-Predict estimates the probability of biochemical failure (BF) at 8 years after RT, taking into account palpation T-category, biopsy Gleason score, the percentage of tumor cells with a Gleason pattern of 4 or 5, the percentage of tumor tissue, initial pretreatment prostate-specific antigen (PSA) level, ADT duration, and RT dose.
Hide
Show More...
P-Predict estimates the probability of biochemical failure (BF) at 8 years after RT, taking into account palpation T-category, biopsy Gleason score, the percentage of tumor cells with a Gleason pattern of 4 or 5, the percentage of tumor tissue, initial pretreatment prostate-specific antigen (PSA) level, ADT duration, and RT dose.
Screenshots
P-Predict FAQ
-
Is P-Predict free?
Yes, P-Predict is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is P-Predict legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does P-Predict cost?
P-Predict is free.
-
What is P-Predict revenue?
To get estimated revenue of P-Predict app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Philippines yet.
Ratings History
P-Predict Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
P-Predict Installs
Last 30 days
P-Predict Revenue
Last 30 daysP-Predict Revenue and Downloads
Gain valuable insights into P-Predict performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Health Fitness
- Publisher
- University of Miami
- Languages
- English
- Recent release
- 2.3 (3 years ago )
- Released on
- Apr 15, 2021 (3 years ago )
- Also available in
- Poland, South Korea, Kuwait, Kazakhstan, Lebanon, Mexico, Malaysia, Netherlands, Norway, New Zealand, Philippines, Pakistan, Japan, Portugal, Romania, Russia, Saudi Arabia, Sweden, Singapore, Thailand, Türkiye, United States, Vietnam, South Africa, Egypt, Australia, Azerbaijan, Belgium, Belarus, Canada, Switzerland, Chile, China, Czechia, Germany, Denmark, Austria, Spain, Finland, France, United Kingdom, Greece, Indonesia, Ireland, Israel, India, Italy
- Last Updated
- 3 weeks ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.